Pharma News India
The drug firm has just launched India's first locally manufactured re-usable insulin pen in the country.
Mumbai, October 11, 2012: The French drug maker, Sanofi is in the process of charting an India-specific strategy in order to increase its share in India's Rs 65,000 crore drug market. The India unit of the drug company has recently launched India's first locally manufactured re...
This launch clearly shows the increasing synergies between Ranbaxy and Daiichi Sankyo.
New Delhi, October 9, 2012: Ranbaxy Laboratories has launched the generic cevimeline hydrochloride capsules in the US market, under an agreement with Daiichi Sankyo Inc. It may be noted here that the capsules are used in treating Sjogren's syndrome.
The expansion is expected to add value in the area of API manufacturing for the company.
Mumbai, October 8, 2012: The Indian pharma company, Dr Reddy's Laboratories (DRL) has expanded its operations in the United Kingdom. The Custom Pharmaceutical Services (CPS) business has been expanded in the areas of development and manufacture of NCE (New Chemical Entities) APIs for use in p...
The two companies have entered into a joint drug discovery deal indicating the rising interest of MNCs in the Indian drug research.
Mumbai, October 4, 2012: Adnivus Pharma, a company promoted by Tata Group has tied up with Japan-based Takeda Pharma inking a joint drug discovery deal. This agreement indicated the rising interest of multinational companies in the Indian drug researc...
The anti-malarial drug from Cipla receives pre-qualification from WHO.
New Delhi, October 3, 2012: Drug firm Cipla said that the anti-malarial drug developed by the Drugs for Neglected Diseases initiative (DNDi) has received pre-qualification from the World Health Organisation (WHO).